Alkomiet Hasan

Cognitive Neuroscience · 2012–2013

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Alkomiet Hasan trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Leucht
  2. Peter B. Jones
  3. John W. Newcomer

Papers from Alkomiet Hasan's perspective

Ordered by how strongly the researchers Alkomiet Hasan trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. (American Journal of Psychiatry)
  2. Second-Generation (Atypical) Antipsychotics and Metabolic Effects (CNS Drugs)
  3. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (New England Journal of Medicine)
  4. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. (The Lancet)
  5. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of… (European psychiatry)
  6. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. (The Lancet)
  7. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. (American Journal of Psychiatry)
  8. Physical health monitoring of patients with schizophrenia. (American Journal of Psychiatry)
  9. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. (American Journal of Psychiatry)
  10. Induction of plasticity in the human motor cortex by paired associative stimulation. (Brain : a journal of neurology)

Their papers